Molecular notes, research context, and compound updates from the Forward laboratory. For research use only.
Retatrutide (RT) occupies a distinct position in metabolic research literature. Where earlier GLP-1 analogs acted on a single receptor class, the triple-agonist design targets GLP-1, GIP, and glucagon receptors simultaneously - enabling study of parallel incretin pathways within a single experimental model.
Preclinical research has focused on the compound's effects on energy homeostasis, glucose regulation, and adipose tissue signaling. The glucagon component distinguishes RT from dual-incretin analogs, adding a hepatic signaling dimension that continues to generate investigation.
Read compound profile →
BPC-157 is a synthetic pentadecapeptide derived from a sequence found in gastric juice. Preclinical research has examined its effects on angiogenic signaling, cellular repair mechanisms, and gastrointestinal cellular processes. It remains one of the more broadly studied research peptides for cellular pathway investigation.
Semax is a synthetic analog of the ACTH(4-10) sequence, studied in Russian neurological research programs. Laboratory investigation has focused on its effects on BDNF expression, neuroprotective signaling, and cognitive pathway modulation in preclinical models.
Epitalon is a synthetic tetrapeptide studied for its effects on telomerase activity in preclinical settings. Research has examined its interactions with the pineal gland and its role in circadian rhythm regulation.
MOTS-C is a peptide encoded within the mitochondrial genome. Preclinical research has examined its role in AMPK pathway activation and mitochondrial function, contributing to a growing body of work on mitochondria-derived signaling peptides.
Kisspeptin is a neuropeptide investigated for its role in hypothalamic-pituitary-gonadal axis signaling. It acts on KISS1R receptors and has been studied in the context of reproductive endocrinology research, with ongoing investigation into its broader neuroendocrine regulatory functions.
Research updates, new compound profiles, and protocol notes. No marketing. No frequency commitment.
Subscribe via ContactAll content in the Forward Journal is provided for general research context and educational purposes only. It does not constitute medical advice, clinical guidance, or a recommendation for any specific research application. All compounds referenced are supplied for laboratory and in vitro research use only. Not for human or veterinary consumption.